Bath & Body Works (NYSE:BBWI) Receives Outperform Rating from Telsey Advisory Group

Telsey Advisory Group restated their outperform rating on shares of Bath & Body Works (NYSE:BBWI) in a research report report published on Monday,Benzinga reports. They currently have a $42.00 price objective on the stock.

BBWI has been the topic of several other research reports. Robert W. Baird decreased their target price on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a research report on Thursday, August 29th. Morgan Stanley decreased their price objective on Bath & Body Works from $56.00 to $51.00 and set an “overweight” rating on the stock in a report on Thursday, September 5th. Evercore ISI dropped their target price on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a report on Wednesday, August 28th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Bath & Body Works from $57.00 to $54.00 and set a “buy” rating on the stock in a research note on Monday, August 26th. Finally, BMO Capital Markets reiterated an “outperform” rating and issued a $50.00 price objective (down previously from $52.00) on shares of Bath & Body Works in a research note on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $42.44.

Bath & Body Works Price Performance

Shares of Bath & Body Works stock opened at $31.45 on Monday. The business has a fifty day simple moving average of $30.26 and a two-hundred day simple moving average of $36.29. Bath & Body Works has a 1 year low of $26.20 and a 1 year high of $52.99. The company has a market capitalization of $6.89 billion, a price-to-earnings ratio of 7.62, a P/E/G ratio of 1.00 and a beta of 1.79.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The company had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.54 billion. As a group, equities analysts anticipate that Bath & Body Works will post 3.18 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be given a dividend of $0.20 per share. The ex-dividend date is Friday, November 22nd. This represents a $0.80 annualized dividend and a dividend yield of 2.54%. Bath & Body Works’s dividend payout ratio is currently 19.37%.

Insider Buying and Selling at Bath & Body Works

In related news, CEO Gina Boswell purchased 6,000 shares of the stock in a transaction dated Wednesday, October 9th. The stock was bought at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the acquisition, the chief executive officer now owns 242,987 shares of the company’s stock, valued at approximately $7,202,134.68. This represents a 2.53 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.27% of the company’s stock.

Institutional Investors Weigh In On Bath & Body Works

Hedge funds and other institutional investors have recently bought and sold shares of the company. TD Private Client Wealth LLC grew its holdings in shares of Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after purchasing an additional 331 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its holdings in Bath & Body Works by 30.6% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 137,610 shares of the company’s stock worth $4,393,000 after buying an additional 32,233 shares during the period. iA Global Asset Management Inc. grew its position in shares of Bath & Body Works by 1,078.2% in the 3rd quarter. iA Global Asset Management Inc. now owns 49,331 shares of the company’s stock valued at $1,575,000 after buying an additional 45,144 shares during the last quarter. Wellington Management Group LLP bought a new stake in Bath & Body Works in the third quarter valued at approximately $8,129,000. Finally, Weiss Asset Management LP increased its position in Bath & Body Works by 29.0% during the 3rd quarter. Weiss Asset Management LP now owns 377,969 shares of the company’s stock valued at $12,065,000 after purchasing an additional 84,873 shares during the period. Institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.